246 related articles for article (PubMed ID: 11023543)
21. Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase.
Lewis AJ; Otake Y; Walle UK; Walle T
Xenobiotica; 2000 Mar; 30(3):253-61. PubMed ID: 10752640
[TBL] [Abstract][Full Text] [Related]
22. The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation.
Davis W; Venitt S; Phillips DH
Carcinogenesis; 1998 May; 19(5):861-6. PubMed ID: 9635875
[TBL] [Abstract][Full Text] [Related]
23. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues.
Brown K; Brown JE; Martin EA; Smith LL; White IN
Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484
[TBL] [Abstract][Full Text] [Related]
24. N-demethylation accompanies alpha-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
Phillips DH; Hewer A; Horton MN; Cole KJ; Carmichael PL; Davis W; Osborne MR
Carcinogenesis; 1999 Oct; 20(10):2003-9. PubMed ID: 10506117
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
[TBL] [Abstract][Full Text] [Related]
26. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
[TBL] [Abstract][Full Text] [Related]
27. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
[TBL] [Abstract][Full Text] [Related]
28. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
[TBL] [Abstract][Full Text] [Related]
29. Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450.
Williams ML; Lennard MS; Martin IJ; Tucker GT
Carcinogenesis; 1994 Dec; 15(12):2733-8. PubMed ID: 8001229
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
31. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
Kupfer D; Mani C; Lee CA; Rifkind AB
Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
[TBL] [Abstract][Full Text] [Related]
32. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.
Sun D; Sharma AK; Dellinger RW; Blevins-Primeau AS; Balliet RM; Chen G; Boyiri T; Amin S; Lazarus P
Drug Metab Dispos; 2007 Nov; 35(11):2006-14. PubMed ID: 17664247
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
[TBL] [Abstract][Full Text] [Related]
34. Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.
Shibutani S; Shaw PM; Suzuki N; Dasaradhi L; Duffel MW; Terashima I
Carcinogenesis; 1998 Nov; 19(11):2007-11. PubMed ID: 9855017
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.
Dehal SS; Kupfer D
Drug Metab Dispos; 1999 Jun; 27(6):681-8. PubMed ID: 10348797
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
[TBL] [Abstract][Full Text] [Related]
37. Species differences in the covalent binding of [14C]tamoxifen to liver microsomes and the forms of cytochrome P450 involved.
White IN; De Matteis F; Gibbs AH; Lim CK; Wolf CR; Henderson C; Smith LL
Biochem Pharmacol; 1995 Apr; 49(8):1035-42. PubMed ID: 7748182
[TBL] [Abstract][Full Text] [Related]
38. Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.
White IN; Carthew P; Davies R; Styles J; Brown K; Brown JE; Smith LL; Martin EA
Carcinogenesis; 2001 Apr; 22(4):553-7. PubMed ID: 11285188
[TBL] [Abstract][Full Text] [Related]
39. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
[TBL] [Abstract][Full Text] [Related]
40. Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro.
Boogaard PJ; Sumner SC; Bond JA
Toxicol Appl Pharmacol; 1996 Feb; 136(2):307-16. PubMed ID: 8619238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
